{"id":"https://openalex.org/A5137370903","orcid":null,"observed_orcids":[],"display_name":"Frieda Shigwedha","raw_author_names":["Frieda Shigwedha"],"full_name":"Frieda Shigwedha","works_count":2,"cited_by_count":2,"summary_stats":{"2yr_mean_citedness":1.0,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5137370903","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I42350008","ror":"https://ror.org/01tqmg467","display_name":"Ministry of Health and Social Services","country_code":"NA","type":"government","lineage":["https://openalex.org/I42350008"]},"years":[2026]},{"institution":{"id":"https://openalex.org/I4405266110","ror":"https://ror.org/00ck8g404","display_name":"Namibia Medicines Regulatory Council","country_code":"NA","type":"healthcare","lineage":["https://openalex.org/I4405266110"]},"years":[2026]}],"last_known_institutions":[{"id":"https://openalex.org/I42350008","ror":"https://ror.org/01tqmg467","display_name":"Ministry of Health and Social Services","country_code":"NA","type":"government","lineage":["https://openalex.org/I42350008"]},{"id":"https://openalex.org/I4405266110","ror":"https://ror.org/00ck8g404","display_name":"Namibia Medicines Regulatory Council","country_code":"NA","type":"healthcare","lineage":["https://openalex.org/I4405266110"]}],"topics":[{"id":"https://openalex.org/T10254","display_name":"Innovations in Medical Education","count":1,"subfield":{"id":"https://openalex.org/subfields/3304","display_name":"Education"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","count":1,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","count":1,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12413","display_name":"Health and Medical Education","count":1,"subfield":{"id":"https://openalex.org/subfields/3600","display_name":"General Health Professions"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12878","display_name":"Pharmaceutical Quality and Counterfeiting","count":1,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12878","display_name":"Pharmaceutical Quality and Counterfeiting","value":1.23e-05,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","value":7.7e-06,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14396","display_name":"Healthcare Regulation","value":4.4e-06,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","value":3.9e-06,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12413","display_name":"Health and Medical Education","value":3e-06,"subfield":{"id":"https://openalex.org/subfields/3600","display_name":"General Health Professions"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"39549134","wikidata":"https://www.wikidata.org/wiki/Q133080","display_name":"Public relations","score":0.4740999937057495},{"id":"144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","score":0.45559999346733093},{"id":"2779622097","wikidata":"https://www.wikidata.org/wiki/Q1417724","display_name":"Capacity building","score":0.43149998784065247},{"id":"535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","score":0.3889999985694885},{"id":"17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","score":0.35030001401901245}],"counts_by_year":[{"year":2026,"works_count":2,"oa_works_count":2,"cited_by_count":2}],"display_name_alternatives":["Frieda Shigwedha"],"block_key":"f shigwedha","works_api_url":"https://api.openalex.org/works?filter=author.id:A5137370903","awards_count":0,"updated_date":"2026-11-04T11:47:51","created_date":"2026-05-30T00:00:00"}